{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:08:39Z","timestamp":1773925719249,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5272,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1046\/j.1523-1755.2001.00795.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:42:40Z","timestamp":1047444160000},"page":"266-271","source":"Crossref","is-referenced-by-count":30,"title":["Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout"],"prefix":"10.1016","volume":"60","author":[{"given":"Ja-Liang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Tzu","family":"Lin-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huei-Hong","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563658808995395","article-title":"Environmental lead exposure and the kidney","volume":"26","author":"Bernard","year":"1988","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archinte.1979.03630380035014","article-title":"Detection and treatment of occupational lead nephropathy","volume":"139","author":"Wedeen","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJM199207163270303","article-title":"Impairment of renal function with increasing blood lead concentrations in the general population: The Cadmibel Study Group","volume":"327","author":"Staessen","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/oxfordjournals.aje.a117330","article-title":"Low-level lead exposure and renal function in the Normative Aging Study","volume":"140","author":"Payton","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/oxfordjournals.aje.a113995","article-title":"The relationship between blood lead levels and blood pressure and its cardiovascular risk implications","volume":"121","author":"Pirkle","year":"1985","journal-title":"Am J Epidemiol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.1984.175","article-title":"Chronic renal failure with gout: A marker of chronic lead poisoning","volume":"26","author":"Craswell","year":"1984","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.1.6059.482","article-title":"Renal insufficiency associated with excessive lead exposure","volume":"1","author":"Campbell","year":"1977","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/20.4.208","article-title":"The relationship of serum uric acid to subclinical blood lead","volume":"20","author":"Baker","year":"1981","journal-title":"Rheumatol Rehabil"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0050","first-page":"1","article-title":"Elevated lead burden in Chinese patients without occupational lead exposure","volume":"18","author":"Lin","year":"1992","journal-title":"Miner Electrolyte Metab"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0055","first-page":"705","article-title":"Body lead stores and urate excretion in men with chronic renal disease","volume":"21","author":"Lin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0060","first-page":"495","article-title":"Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?","volume":"8","author":"Lin","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00002281-199605000-00014","article-title":"Gouty arthritis and uric acid metabolism","volume":"8","author":"Wise","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ajcn\/33.1.4","article-title":"Urinary nitrogen output as a validity test in dietary surveys","volume":"33","author":"Isaksson","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000456328602300101","article-title":"Analytical reviews in clinical biochemistry: The estimation of creatinine","volume":"23","author":"Spencer","year":"1986","journal-title":"Ann Clin Biochem"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/000456328402100512","article-title":"Problems associated with the measurement of uric acid using two enzyme-mediated reaction systems","volume":"21","author":"James","year":"1984","journal-title":"Ann Clin Biochem"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-73-3-359","article-title":"Diminished renal urate secretion per nephron as a basis for primary gout","volume":"73","author":"Rieselbach","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000168498","article-title":"Disappearance of immune deposits with EDTA chelation therapy in a case of IgA nephropathy","volume":"12","author":"Lin","year":"1992","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ndt\/12.2.364","article-title":"Reversible hypothyroidism with EDTA chelation therapy in a patient with elevated lead burden and chronic renal insufficiency","volume":"12","author":"Lin","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000183696","article-title":"Urinary lead excretion in uremic patients","volume":"42","author":"Behringer","year":"1986","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM198102263040905","article-title":"The role of lead in gout nephropathy","volume":"304","author":"Batuman","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000183908","article-title":"Chronic lead accumulation as a possible cause of renal failure in gouty patients","volume":"44","author":"Colleoni","year":"1986","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0115","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/ndt\/11.9.1775","article-title":"Occult lead intoxication as a cause of hypertension and renal failure","volume":"11","author":"Sanchez-Fructuoso","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/art.1780260901","article-title":"Moonshine and lead: Relationship to the pathogenesis of hyperuricemia in gout","volume":"26","author":"Reynolds","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000189557","article-title":"Purine metabolism in patients with gout: The role of lead","volume":"75","author":"Miranda-Carus","year":"1997","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0013-9351(05)80203-8","article-title":"Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA)","volume":"58","author":"Khalil-Manesh","year":"1992","journal-title":"Environ Res"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1445-5994.1971.tb02545.x","article-title":"The relative contributions of tubular reabsorption and secretion to urate excretion in lead nephropathy","volume":"1","author":"Emmerson","year":"1971","journal-title":"Aust N Z J Med"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ki.1991.68","article-title":"Endothelium-derived relaxing and contracting factors: Perspectives in nephrology","volume":"39","author":"Luscher","year":"1991","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00795.x_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-197803000-00004","article-title":"The renal vasculature in early essential hypertension: Evidence for a pathogenetic role","volume":"57","author":"Hollenberg","year":"1978","journal-title":"Medicine"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815478433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815478433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:42:50Z","timestamp":1580949770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815478433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0085253815478433"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00795.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}